DNAlytics aims at being the reference data-related solution provider for personalized and predictive medicine, from R&D to patients. In particular, DNAlytics will perform data analysis at various levels of the customers development pipelines in order to design innovative diagnostic, prognostic and theranostic* solutions. These analyses will also cover automated biomarker identification. DNAlytics will further provide IT tools to deploy those predictive solution, namely over the web, directly to clinicians and/or patients. DNAlytics technology for personalized and predictive medicine in clinical research and its applications leads to four main benefits:
- for the healthcare industry: reductions of development risk and duration, increased ROI, as well as opening new avenues of development.
- for the diagnostic industry: provide real diagnostics and decision support tools, instead of merely providing measurement technologies.
- for the patient: an enhanced and tailored health management.
- for society: reduced public health expenses (since therapies will get more targeted and effective, and also because diagnostic will be posed earlier and more accurately)
To reach its objectives, DNAlytics provides expert knowhow in data mining, machine learning, statistics, intensive computing, data management and web technologies. This set of expertises is complementary to those usually encountered in the healthcare industry. Support activities such as regulatory affairs management, sales and marketing will also be supported. By its contribution overall, DNAlytics will thus help its partners and customers adopt an adequate positioning in the field of predictive and personalized medicine. DNAlytics deploys a business model with two mutually-reinforcing activities. The first one is based on a service activity serving the R&D departments of our customers, pharmaceutical or biotech companies as well as academic laboratories active in clinical research.
The second activity is more product-oriented, consisting of a web platform allowing the commercialization and management of diagnostic kits, with the specificity of offering on-demand computation of complex diagnostics, prognostics or treatment response predictions. This platform is intended to serve the use of third-tiers diagnostic products, just like Amazon commercializes products from other companies, but also DNAlytics own diagnostic kits. A first example is already available with a kit for arthritis early differential diagnostic: RheumaKit. * Theranostic is the field of treatment respons prediction or adverse event prediction
Site internet: http://dnalytics.com/